期刊文献+

百日咳鲍特菌红霉素耐药性及耐药相关分子特征分析 被引量:8

Resistance to Erythromycin and Molecular Characteristics of Bordetella pertussis
原文传递
导出
摘要 目的分析百日咳鲍特菌(Bordetella pertussis,Bp)红霉素耐药性并对其耐药相关分子特征进行检测。方法对分离自西安市2014年百日咳报告病例中的Bp通过E-Test检测其红霉素耐药性,通过聚合酶链反应(PCR)和PCR-测序方法分别检测可能出现的耐药基因及耐药相关位点改变。结果 10株Bp临床株分布于西安市6个区县,对红霉素的最小抑菌浓度(MIC)均>256μg/ml,所有菌株都出现23S rRNA基因的A2047G突变,未见其他耐药基因及位点改变。结论西安市的红霉素耐药Bp已较为普遍,23S rRNA基因的A2047G突变可能是其最主要的耐药机制。应在百日咳监测的同时加强病原的抗生素耐药性监测及耐药相关分子的检测。 Objective To determine susceptibilities to erythromycin and the molecular characteristics of Bordetella pertussis(Bp).Methods Ten Bp strains,isolated from reported pertussis cases in Xi'an in 2014,were tested by E-Test methods to determine minimal inhibitory concentrations(MIC) to erythromycin.Polymerase chain reaction(PCR) and PCR-sequencing methods were used to identify resistant genes and relative changes such as deletions,insertions or mutations.Results 10 isolated strains were distributed in 6 counties of Xi'an.The MIC to erythromycin for all strains was 256μg/ml,and these strains were defined as erythromycin resistant strains.A genetic mutation occurred at the A2047G site in the 23 S rRNA gene of all strains;other relative resistant genes or changes were not seen.Conclusions Erythromycin resistant Bp stains were prevalent in Xi'an.The common resistance mechanism was mutation of A2047G in the 23 S rRNA gene of Bp.We suggest strengthening pertussis surveillance,especially for erythromycin resistant Bp.
出处 《中国疫苗和免疫》 北大核心 2016年第2期180-182,179,共4页 Chinese Journal of Vaccines and Immunization
基金 陕西省自然科学基金项目(编号2015JM8391)
关键词 百日咳鲍特菌 耐药 分子特征 Bordetella pertussis Resistance Molecular Characteristic
  • 相关文献

参考文献11

  • 1Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella per- tussis and other Bordetella subspecies [ J ]. Clin Microbiol Rev.2005, 18(2): 326-382.
  • 2Erythromycin-resistant BordeteUa pertussis-Yuma County, Arizona, May-Oetober 1994[J]. MMWR Morb Mortal Wkly Rep. 1994, 43 (44) : 807-810.
  • 3Berti E, Venturini E, Galli L, et al pertussis infection in neonates [ l . 2014, 12(12): 1515-1531.
  • 4Management and prevention of Expert Rev Anti Infect Ther. Wang Z, Cui Z, Li Y, et al. High prevalence of erythromyein-re- sistant Bordetella pertusis in Xi'an, China[ J]. Clin Mierobiol In- feet. 2014, 20( 11 ) : 0825-8250830.
  • 5Allen VG, Farrell DJ, Rebbapragada A, et al. Moleeular analysis of antimierobial resistanee mechanisms in Neisseria gonorrhoeae iso- lates from Ontario, Canada [ J ]. Antimierob Agents Chemother. 2011, 55(2) : 703-712.
  • 6Suteliffe J, Grebe T, Tait-Kamradt A, et al. Deteetion of erythro- mycin-resistant determinants by PCR [ J ]. Antimierob Agents Che- mother. 1996, 40(11 ) : 2562-2566.
  • 7Guiso N. Bordetella pertussis : why is it still circulating [ J ]. J In- feet. 2014, 68 Suppl 1: S119-124.
  • 8Yang Y, Yao K, Ma X, et al. Variation in Bordetella pertussis Sus- ceptibility to Erythromycin and Virulence-Related Genotype Changes in China (1970-2014) [J]. PLoS One. 2015, 10 (9): e0138941.
  • 9罗洁,王慧欣,袁林,顾松,姜敏,丁翊君,郭丹,姚开虎,王亚娟.新生儿百日咳临床特点和致病菌耐药性分析[J].中国当代儿科杂志,2014,16(10):975-978. 被引量:22
  • 10Alekshun MN, Levy SB. Molecular mechanisms of antibacterial muhidrug resistance[J]. Cell 2007, 128(6) : 1037-1050.

二级参考文献11

  • 1侯启明,马霄,田博,刘德铮,肖詹荣,杨晓明,陈平纡,项美娟,付惠兰,吴玫,王梨苹,梁雅文,张路民,张庶民.中国不同区域婴儿抗百日咳 白喉 破伤风母体抗体水平的调查[J].中国计划免疫,2006,12(3):209-211. 被引量:9
  • 2von Konig CH, Halperin S, Riffelmann M, et al. Pertussis ofadults and infants[J]. Lancet Infect Dis, 2002,2(12): 744-750.
  • 3Wendelboe AM, Hudgens MG, Poole C, et al. Estimating therole of casual contact from the community in transmissionof Bordetella pertussis to young infants[J]. Emerg ThemesEpidemiol, 2007, 4: 15.
  • 4Gregory DS. Pertussis: a disease affecting all ages[J]. Am FamPhysician, 2006, 74(3): 420-426.
  • 5Montella S, De Stefano S, Sperli F, et al. Increased risk ofchronic suppurative lung disease after measles or pertussis innon-vaccinated children[J]. Vaccine, 2007, 25(3): 402-403.
  • 6CDC. Updated recommendations or use of tetanus toxoids,reduced diphtheria toxiod and acellular pertussis vaccine(Tdap) in pregnant women and persons who have or anticipatehaving close contact with an infant aged<12 months-AdvisoryCommittee on Immunization Practices(ACIP), 2011[J]. MMWR,2011,60(41): 1424-1426.
  • 7De Serres G, Boulianne N, Duval B. Field effectiveness oferythromycin prophylaxis to prevent pertussis within families[J].Pediatr Infect Dis J,1995, 14(11): 969-975.
  • 8Zhang Q, Li M, Wang L, et al. High-resolution melting analysisfor the detection of two erythromycin-resistant Bordetellapertussis strains carried by healthy schoolchildren in China[J].ClinMicrobiolInfect, 2013,19(6): E260-E262.
  • 9Wang Z, Li Y, Hou T, et al. Appearance of macrolide-resistantBordetella pertussis strains in China[J]. Antimicrob AgentsChemother,2013,57(10): 5193-5194.
  • 10Wang Z,Cui Z, Li Y, et al. High prevalence of erythromycin-resistant Bordetella pertussis in Xi'an, China[J], Clin MicrobiolInfect, 2014. doi: 10.1111/1469-0691.12671. [Epub ahead ofprint].

共引文献21

同被引文献50

引证文献8

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部